PhD, Epidemiology
Health Insurance Portability and Accountability Act (HIPAA) Certifcation
University of Michigan, Ann Arbor, MI
Good Clinical Practices for Clinical Investigsations of Devices and Certification in Human Subjects Research (HSR)
Collaborative Institutional Training Initiative (CITI Program), Ann Arbor, MI
MPH, Epidemiology
BS, Health & Disease and Psychology
University of Toronto, Toronto, Canada
Anam Khan, PhD, MPH is a Research Pharmacoepidemiologist in the Pharmacoepidemiology and Risk Management group with RTI-HS. Dr. Khan has over 7 years of experience in conducting epidemiology research studies in academia and consulting. Prior to joining RTI-HS, Dr. Khan served as a consultant to the pharmaceutical industry in the United States, where she supported clients by working on drug utilization and safety studies, as well as provided strategic advising. She has experience designing observational pharmacoepidemiology studies, developing protocols and analysis plans, statistical data analysis and interpretation, and producing study reports, as well as disseminating information to clients and other stakeholders. Dr. Khan also has experience working as an epidemiologist in academic, research, and public health institutes in Canada, where she worked with a variety of real-world data sources to conduct observational studies and health economics and outcomes research.
Dr. Khan is trained in advanced epidemiologic designs and methods and has successfully applied rigorous epidemiological methods for missing data, confounder control, target trial emulations, and longitudinal, repeated measures studies to answer important regulatory, policy, and research questions. Dr. Khan has experience with a variety of study designs and has extensive experience working with real-world data sources such as electronic medical records, claims and mortality data, and disease-specific registries in the United States and Canada. Additionally, Dr. Khan has expertise developing and using neighborhood-level measures of social determinants of health.
Dr. Khan has experience working on and leading large-scale projects with interdisciplinary teams of researchers, clinical and data partners, policy makers, and patients. She has worked on projects that span a variety of therapeutic and clinical areas including cardiovascular and metabolic disease, oncology, ophthalmology, gerontology, Alzheimer’s disease and dementia, and rare diseases.